Krüppel-like factor-11, a transcription factor involved in diabetes mellitus, suppresses endothelial cell activation via the nuclear factor-κB signaling pathway.
Krüppel-like factor-11, a transcription factor involved in diabetes mellitus, suppresses endothelial cell activation via the nuclear factor-κB signaling pathway.
复制标题
DOI:
10.1161/atvbaha.112.300349
复制
发表时间:
2012-12
期刊:
影响因子:
--
通讯作者:
Chen YE
中科院分区:
文献类型:
--
作者:
Fan Y;Guo Y;Zhang J;Subramaniam M;Song CZ;Urrutia R;Chen YE
Endothelial cell (EC) inflammatory status is critical to many vascular diseases. Emerging data demonstrate that mutations of Krüppel like factor-11 (KLF11), a gene coding maturity-onset diabetes of the young type 7 (MODY7), contribute to the development of neonatal diabetes. However, the function of KLF11 in the cardiovascular system still remains to be uncovered. In this study, we aimed to investigate the role of KLF11 in vascular endothelial inflammation. KLF11 is highly expressed in vascular endothelial cells (ECs) and induced by pro-inflammatory stimuli. Adenovirus-mediated KLF11 overexpression inhibits expression of tumor necrosis factors (TNF)-α-induced adhesion molecules. Moreover, siRNA-mediated KLF11 knockdown augments the pro-inflammatory status in ECs. KLF11 inhibits promoter activity of adhesion molecules induced by TNF-α and NF-κB p65 overexpression. Mechanistically, KLF11 potently inhibits NF-κB signaling pathway via physical interaction with p65. Furthermore, KLF11 knockdown results in increased binding of p65 to VCAM-1 and E-selectin promoters. At the whole organism level, KLF11-/- mice exhibit a significant increase in leukocyte recruitment to ECs after lipopolysaccharide (LPS) administration. Taken together, our data demonstrate for the first time that KLF11 is a suppressor of EC inflammatory activation suggesting that KLF11constitutes a novel potential molecular target for inhibition of vascular inflammatory diseases.